Health Care & Life Sciences » Pharmaceuticals | Dechra Pharmaceuticals PLC

Dechra Pharmaceuticals PLC | Income Statement

Fiscal year is July-June. All values GBP Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
193,571.00
203,480.00
247,562.00
359,275.00
407,100.00
Cost of Goods Sold (COGS) incl. D&A
102,406.00
105,209.00
135,271.00
208,004.00
238,800.00
Gross Income
91,165.00
98,271.00
112,291.00
151,271.00
168,300.00
SG&A Expense
65,540.00
71,746.00
85,584.00
114,070.00
125,500.00
EBIT
25,625.00
26,525.00
-
37,201.00
42,800.00
Unusual Expense
1,876.00
1,420.00
8,911.00
3,708.00
8,200.00
Non Operating Income/Expense
113.00
2,135.00
897.00
40.00
1,200.00
Interest Expense
2,561.00
1,460.00
2,372.00
5,016.00
6,800.00
Pretax Income
21,442.00
25,806.00
14,548.00
28,721.00
29,200.00
Income Tax
2,026.00
6,347.00
2,036.00
2,452.00
7,200.00
Equity in Affiliates
-
-
-
159.00
300.00
Consolidated Net Income
19,416.00
19,459.00
12,512.00
26,110.00
36,100.00
Net Income
19,416.00
19,459.00
12,668.00
26,105.00
36,100.00
Net Income After Extraordinaries
20,215.00
19,459.00
12,668.00
26,105.00
36,100.00
Net Income Available to Common
20,436.00
19,459.00
12,668.00
26,105.00
36,100.00
EPS (Basic)
0.68
0.22
0.14
0.28
0.37
Basic Shares Outstanding
87,385.70
87,890.30
89,380.40
92,963.00
96,942.00
EPS (Diluted)
0.67
0.22
0.14
0.28
0.37
Diluted Shares Outstanding
87,698.50
88,495.20
90,008.70
93,479.00
97,451.20
EBITDA
46,162.00
48,063.00
52,022.00
84,800.00
104,200.00
Non-Operating Interest Income
141.00
26.00
21.00
204.00
200.00
Minority Interest Expense
-
-
156.00
5.00
-

About Dechra Pharmaceuticals

View Profile
Address
Cheshire Business Park
Northwich Cheshire CW9 7UA
United Kingdom
Employees -
Website http://dechra.com
Updated 07/08/2019
Dechra Pharmaceuticals PLC is a holding company, which engages in the veterinary pharmaceuticals and related products business. It operates through the following segments: European Pharmaceuticals; North American Pharmaceuticals; and Pharmaceuticals Research and Development. The European Pharmaceuticals segment markets and sells licensed pharmaceuticals and specialist pet foods to the veterinary profession in Europe.